Clinical Trials Browser

Precursor Cell Lymphoblastic Leukemia-Lymphoma × brexucabtagene autoleucel × 1 year × Clear all

NCT06144606 2026-02-09

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03642626 2026-01-23

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Phase 2 Active not recruiting

150 enrolled 23 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma